Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Headache, Influenza like illness, Pyrexia, Rhinorrhoea
Clinical narrative: experienced flu-like symptoms; runny nose; fever; joint pain; spring allergy; Headache; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/lot number: Not reported, Expiry date: Not Reported), via an unspecified route of administration on 13Mar2021 as dose 1, single for covid-19 immunisation. The patient medical history included spring (seasonal) allergy and concomitant medications were not reported. The patient reported that 2 weeks after her 1st dose of the Pfizer-BioNTech Covid-19 Vaccine, she experienced flu-like symptoms such as runny nose, fever, and joint pain. She said she is unsure if this is from the vaccine or from her spring allergy. She wants to know if it would still be safe for her to receive the 2nd dose. She also wants to know if it is normal that the side effects appeared 2 weeks after the 1st dose, and if it would be worse/stronger after the 2nd dose. Warm transfer the consumer to DSU, but all agents were busy and unavailable. Response: Responded from the attached SRDs, "CONS-what are the risks of the vaccine (v5.0)" and "CONS-who should not get the vaccine (v3.0). They told the consumer that the vaccine is different for everyone so Pfizer cannot tell whether the side effects after the 2nd dose would be stronger or not. They also referred her to her HCP for more guidance. The patient also wants to know how long after the 2nd dose will the Pfizer-BioNTech Covid-19 Vaccine be effective. She also wants to know if she could still be infected with the virus after receiving both doses of the vaccine. Response: Responded from the attached SRDs, "CONS-What is the efficacy after one dose US (v3.0)" and "CONS - post-vaccination precautions - wearing a mask and social distancing after receiving the vaccine (v5.0)." The patient said that her 1st dose was on 13Mar and her 2nd dose is scheduled tomorrow, 31Mar. She wants to know if this is too early. Response: Responded from the attached SRD, "CONS-Pfizer-BioNTech COVID-19 Vaccine - timing of Dose 2 (v1.0)." The patient wanted to know if she should go ahead and receive the 2nd dose of the Pfizer-BioNTech Covid-19 Vaccine if she takes the Covid test and it comes out negative. And if it comes out positive, she wants to know if she should also proceed with the 2nd dose. Response: Responded from the attached SRD, "CONS-Can I Receive the Vaccine with a Prior or Current COVID-19 Diagnosis (US) (v2.0)." The patient was scheduled for her second dose of the vaccine tomorrow. She experienced flu-like symptoms (fever, joint pain, headache, runny nose) over the weekend. She called in to ask if she can take the second dose. She got her first dose on 13Mar2021. With that, she also asked if it is too early because it is not 21 days after the first dose. On an unspecified date, the patient experienced flu-like symptoms, runny nose, fever, joint pain, spring allergy, headache. Outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.